From learning what appeals to investors and increasing the public’s awareness of your products, there are huge benefits to be gained from winning competitions such as Bright SCIdea. So, how can you benefit from entering and what’s in store from this year’s shortlisted teams?
There was a fine article recently in Nature that crystallised the many benefits of entering science competitions, which extend far beyond the coveted prize money.
Winning the competition can take your product from obscurity into the eyes and minds of the public. Importantly, winning immediately gives your innovation credibility as your product (and your vision for it) will inevitably have been vetted by a team of expert judges.
You will also gain valuable publicity. Not only will the organisers promote these innovations, the new-found exposure will increase traffic to your own website and social channels.
Another really important facet of these competitions is that they help develop business sense in line with scientific innovation. In the aforementioned Nature piece, Ulrich Betz, Vice-president of Innovation at Merck, said: ‘Joining competitions can be a useful way for researcher-entrepreneurs to learn what appeals to investors and companies — training that many academic researchers lack… Participants have told me they’ve become more confident working in science and business after taking part.’
Indeed, this tallies with the experiences of last year’s BrightSCIdea winners, Metallogen. The team developed a novel nanoparticle spray that assists the natural process of phytoremediation to extract rare metals from mining. These metals can be sold on the market while decontaminating land next to mining sites at the same time.
Last year’s Bright SCIdea winners used a novel approach to boost metal recovery on old mining sites and decontaminate the land.
However, having an ingenious idea is one thing. Bringing it to market is another. And this is where the training for all the shortlisted teams helped. Metallogen’s John O’Sullivan and Rafael Hunt-Stokes said: ‘The competition has also taught us how to carry out market research and put together a cogent business plan, with the pitching training giving us the ability to convey our business idea in a compelling manner to investors and other stakeholders.’
>> Inspired by Metallogen’s success at Bright SCIdea? Read more about them in our news article.
So, from network building to training and advice on key areas such as intellectual property, these competitions can sharpen your innovations and bring them to that all-important next stage. That’s exactly what the shortlisted teams for this year’s BrightSCIdea plan to do.
This year’s entrants have certainly taken it upon themselves to tackle some of society’s grandest challenges. The Eolic Wall team, hailing all the way from the National University of Engineering in Peru and Universidade Estadual Paulista in Brazil, has created a wind energy system to help in our low-carbon energy transition. The Unmasked team (from the University of Durham) is also seeking to address the UK energy crisis while tackling waste by producing insulation materials from disposable face masks.
In health, the BioTech Inov (University of Coimbra, Portugal) team has entered a ‘highly efficient and versatile nanotechnological subcutaneous biomedical device with a high lifespan’, and the Hatton Cross team (from University of Warwick, QMUL, and Imperial College, London) has also submitted a wearable device that aims to enhance the wearer’s quality of life.
In an effort to address mental wellbeing, the Happy BioPatch team (from Oxford University and Manchester University) has created ‘a wearable gadget which continuously monitors cortisol levels aiming to prevent serious consequences as a result of stress’. Finally, the CardiaTec team (from the University of Cambridge) is specialising in tackling cardiovascular disease.
There’s so much to be gained from being part of competitions such as BrightSCIdea. We can’t wait to hear from the leaders of tomorrow.
Who knows? Maybe this will be the first you hear from a future Nobel prize winner?
>> Keep an eye out on Twitter for all of the wonderful innovations in this year’s BrightSCIdea competition at: @SCIupdate.
Innovation and close collaboration provided the platform for discussions at CIEX 2021. SCI CEO Sharon Todd gives her perspective on the two-day event.
Sharon Todd, SCI CEO
It’s always great to meet new – and old – contacts at events. For so many months, crossing borders wasn’t possible, physically at least, due to the Covid-19 pandemic. Thankfully, the Chemical Innovation Conference (CIEX) provided a welcome change.
On 6 and 7 October, we came together in Frankfurt to discuss the challenges and opportunities in our sector. It was an honour for me to give the opening address – in the same year as SCI’s 140th anniversary.
Indeed, this year’s event included a well-paced mixture of talks and panel events that addressed post-pandemic difficulties, the challenges of climate change, the need to innovate and much more.
The chemical using industries face an array of challenges besides the practical fallout from the Covid-19 pandemic. Brexit, new regulations, supply chain issues, climate change, sustainability, and geo-political unrest pose significant problems
As an innovation hub, SCI connects industry, academia, patent lawyers, consultants, entrepreneurs and government, and other organisations. And I like to think of CIEX as an innovation hub too.
We have no choice but to innovate, but we must do so in a collaborative, sustainable way. The climate change emergency, for example, means society is looking to chemistry to help find long-term innovative solutions. That’s what made CIEX such an apt time for those in the industry to come together and navigate these challenges.
Innovating beyond barriers
The theme of this year’s event was ‘Game-Changing through Collaboration’. But I also thought of it as Crossing Borders – not just physical borders, but getting through the barriers that block innovation. These barriers hold back the translation of scientific solutions from the laboratory into business and, ultimately, into society.
Our sector is in the spotlight as never before and we can shape a better future. The debates at this year’s CIEX, and the exchange of ideas that took place, will help move us all forward. And what an exchange of ideas it proved to be.
We heard from an amazing line-up of speakers, addressing some of the industry’s most salient issues. BASF’s Christian Beil spoke about how best to leverage lean experimentation and rapid prototyping to improve customer centricity in product design, while Iris AI’s Anita Schjoll Brede described how we can reimagine the R&D work environment.
Ineos Styrolution plans to recycle polystyrene using thermal decomposition or by washing and remelting waste.
Furthermore, Johnson & Johnson’s Luis Allo spoke about the rise of consumer awareness as a driver for innovation. He provided interesting insights on accessing information on real customer trends and needs. Dupont’s Fred Godbille also described several tried and tested methods to assess the voice of the customer.
Elsewhere, Croda’s Nick Challoner assessed how we can unlock innovation through collaboration and partnerships. He also provided an overview of how Croda interacts with universities. On a more technical note, Roman Honeker of Ineos Styrolution outlined the company’s plans to recycle polystyrene using thermal decomposition or by washing and remelting waste.
The discussion on ‘how SMEs interact with corporates’ provided another of the event highlights, with contributions from Clariant, BASF, Chemstars, and SCI’s David Bott. Delegates discussed how SMEs sometimes oversell the potential of their products (without necessarily having much real-world experience) and the allegedly slow-moving, risk-averse nature of some corporates.
Throughout the event, attendees examined what we can do better, how this can be achieved, and the resources needed to make this happen. After all, we must be nimble and flexible in these times of political and social uncertainty.
We can cross borders together – physically and virtually – via close collaboration. And we can cross the borders of what’s possible innovation-wise, removing barriers and journeying into new territory for us all.
To celebrate Black History Month, we take a look back at some of the great Black scientists and innovators. From laser eye surgery to the gas mask, here are some of the seminal contributions made by these ingenious inventors.
 Lewis Howard Latimer – Image credit: Unknown author Unknown author, Public domain, via Wikimedia Commons
 Leonidas Berry - Image credit: Adundi, CC BY-SA 4.0, https://creativecommons.org/licenses/by-sa/4.0, via Wikimedia Commons
 Betty Harris – Image credit: https://www.blackpast.org/african-american-history/harris-betty-wright-1940/ - Fair use image
 Patricia Bath - Image credit: National Library of Medicine, Public domain, via Wikimedia Commons
 Philip Emeagwali - Image credit: SakaMese, CC BY-SA 4.0, https://creativecommons.org/licenses/by-sa/4.0, via Wikimedia Commons
1880 – Johnson Powell
Have you ever used eye protectors to protect yourself against the glare of intense light? For those working in extreme environments such as fires and furnaces, Johnson Powell’s eye protectors will have been a sight for sore eyes.
1881 – James Wormley
James Wormley invented a life-saving apparatus for boats. His contraption included a string of floats that extended from a ship’s side via a sliding rod with projecting arms. The famous hotelier was also said to be at President Abraham Lincoln’s bedside when he died.
Image Credit: Unknown author, Public domain, via Wikimedia Commons
1882 – Lewis Howard Latimer
Lewis Howard Latimer is probably best known for inventing a durable carbon filament that was key to the success of the electric light bulb. Latimer also invented an evaporative air conditioner and even drafted the drawings to secure the patent for Alexander Graham Bell’s little known invention… the telephone.
>> Click here for more on Lewis Howard Latimer’s extraordinary contribution to science.
1912 – Garrett Morgan
Imagine using your own invention to save people’s lives? That’s exactly what Garrett Morgan did when he donned his patented smoke hood to rescue trapped men from a smoke-filled tunnel beneath Lake Erie. Morgan’s device later evolved into a gas mask, and he also invented a three-position traffic signal, hair straightening cream, and a self-extinguishing cigarette for good measure.
1916 – Madeline M. Turner
Madeline M. Turner’s ingenious invention was the fruit of her own frustration. Turner grew tired of squeezing oranges for her glass of juice, so she created the fruit press machine to solve the problem.
1932 – Richard Spikes
It’s safe to say Richard Spikes was a polymath. The American inventor created an automatic gear shift device for cars, a pressurised beer tap, and a horizontally swinging barber’s chair – all while working as a teacher and barber and being a capable pianist and violinist.
Image Credit: Adundi, CC BY-SA 4.0, via Wikimedia Commons
1966 – Leonidas Berry
This doctor and civil rights advocate invented the Eder-Berry gastroscopy endoscope in 1955, which helped doctors to biopsy the inside of the stomach without surgery. According to the US National Library of Medicine, ‘the Eder-Berry biopsy attachment made the gastroscope the first direct-vision suction instrument used for taking tissue samples during gastroscopic examination’.
Image Credit: https://www.blackpast.org/african-american-history/harris-betty-wright-1940/ - fair use image
1984 – Betty Harris
Perhaps the most explosive discovery of all belongs to Betty Harris. Harris’ spot test for detecting 1,3,5-triamino-2,4,6-trinitrobenzene in the field is used by US Homeland Security today to check for nitroaromatic explosives. In her spare time, Harris has even found the time to work with the Girl Scouts to develop a badge based on Chemistry.
>> SCI is proud to support #BlackinChem. Take a look at some of our recent work.
Image Credit: National Library of Medicine, Public domain, via Wikimedia Commons
1988 – Patricia Bath
Patricia Bath has helped return the gift of sight to thousands of people. The US ophthalmologist invented a quick and painless device that dissolves cataracts with a laser and cleans the eye, enabling the simple insertion of a new lens. Her laserphaco probe is still in use today.
Image Credit: Philip Emeagwali - SakaMese, CC BY-SA 4.0, via Wikimedia Commons
1989 – Philip Emeagwali
Nigerian computer scientist Philip Emeagwali won the prestigious1989 Gordon Bell Prize in Price Performance for a high-performance computer application that used computational fluid dynamics in oil-reservoir modelling. In the same year, Emeagwali also claimed to perform the world’s fastest computation – 3.1 billion calculations per second – using just the power of the internet.
2002 – Donald K. Jones
Donald K Jones made a notable contribution to medicine with his invention of a detachable balloon embolisation device that reduces the size of aneurysms (bulges in blood vessels). The endovascular occlusion device is implanted into the body, whereupon its clever balloon system and adhesive materials reduce the size of aneurysms.
>> Which barriers still block the way for Black chemists? Read Claudio Lourenco’s story.
We need to create more diverse paths into research and scientific innovation. Professor Dame Ottoline Leyser, Chief Executive of UK Research and Innovation, explains how industry clusters and a change of mindset could help.
What do you picture when someone mentions a chemist? Maybe you see someone like you working in a lab or office with your colleagues.
But what do people at the bus stop think? What would a secondary school student say? Do they see someone like them – or do they imagine an Einstein-like figure hidden away in a dark room with crazed hair and test tubes?
One of the most interesting messages from Professor Dame Ottoline Leyser’s Fuelling the Future: science, society and the research and innovation system talk on 29 September was the need to make sure science and technology are seen as viable careers for people throughout society.
Prof Dame Ottoline Leyser
You don’t need to be a genius to work in research and innovation. You don’t necessarily need to be a specialist, and you certainly don’t need to be hunched over a microscope with a jumble of figures and formulae on a board behind you. An array of different people, technical and non-technical, are needed to make the sector thrive.
Part of Dame Ottoline’s job as Chief Executive of UK Research and Innovation (UKRI) is to improve access to these sectors and to make sure that great ideas aren’t lost due to daunting entry barriers.
‘It’s a huge challenge,’ she said. ‘A large part of the challenge is the narrow concept that we all have of what a researcher and innovator look like.’
Leyser spoke about the need to create diverse routes through the system rather than squeezing everyone through the same narrow path. ‘The assessment criteria we use for individuals have become narrower and narrower,’ she added. ‘Some of it, ironically, is to make the system fairer, but objectivity in creativity is a total pipe dream. You end up crushing creativity by narrowing the criteria.’
She noted that those with mixed careers – interwoven with varied experiences – are to be welcomed. ‘That’s nothing to do with compromising excellence,’ she said. ‘Real excellence comes in multiple forms.’
>> Would you like to attend more talks like this one? Check out our Events page.
However, Leyser also spoke of the need to level up the UK from a productivity perspective. One way to do this is through smart specialisation and industry clusters. She mentioned Lincoln as an area where this approach worked well. Lincoln is home to extensive agriculture and the multinational technology corporation Siemens. As such, it made sense to help make it a centre for agricultural robotics.
UKRI is investing heavily in research and innovation into Net Zero energy solutions.
As the largest public funder of research and innovation in the UK, UKRI has a major role to play in funding such industry clusters and intelligent innovation. It has funded more than 54,000 researchers and innovators, and UKRI grants have generated almost 900 spinouts since 2004.
These include Oxford Nanopore, a biotech company whose DNA sequencing technology is now valued at £2.5bn. It has also cast an eye on the future, including delivering more than £1bn in R&D relevant to Artificial Intelligence and in excess of £1bn towards Net Zero energy solutions.
Leyser noted that the UKRI’s goal is to embed research and innovation more broadly across society – for it to be ‘by the people and for the people, rather than the exclusive domain of the privileged few’.
It is a grand challenge, but such sentiments are certainly encouraging.
SCI was pleased to support #BlackInChem, working alongside our Corporate Partners and members to amplify the voices of our Black chemists.
We have heard stories from several Black chemists who highlighted the steps being taken by many companies to increase diversity. But we can also see that there are many more steps that can be taken to encourage the next generation of budding Black chemists and scientists.
#BlackInChem has had support from Scott Bader, an SCI Corporate Partner, with both Damilola Adebayo and Luyanda Mbongwa sharing their perspectives as employees of Scott Bader. Elsewhere, Cláudio Laurenço gave a compelling account of his journey to become a post-doctoral research associate at a leading consumer goods company.
Cláudio Laurenço worked for free and was overlooked before eventually securing his PhD and starting his career in chemistry.
These chemists are following in the footsteps of some pioneering Black scientists such as Percy Lavone Julian, who has been profiled on the SCI Blog.
Many organisations have expressed their support and shared thoughts on what steps they are taking to encourage and ensure diversity. Indeed, #BlackInChem is a global effort and companies such as GSK have shown their support as well as numerous Black chemists talking about their experiences and achievements over the last week.
Percy Lavon Julian’s pioneering work enabled a step-change in the treatment of glaucoma | Editorial credit: spatuletail / Shutterstock.com
Over the coming months, we will be profiling other Black chemists, past and present, and continuing the dialogue around diversity.
>> We’re always keen to hear about diverse perspectives within chemistry. If you’d like to share your story, please contact: firstname.lastname@example.org or email@example.com.
For Cláudio Lourenço, the path from student to multidisciplinary scientist has been far from smooth. The Postdoctoral Research Associate reflects on the institutional challenges that almost made him give up, the mentor whose support was so important, and the barriers that block the way for young Black chemists.
Please give a brief outline of your role.
I work for a leading consumer goods company. I am a multi-disciplinary scientist contributing to the development of novel formulations for household products.
Why are you supporting #BlackInChem?
I’m supporting #BlackInChem because I am a champion for diversity. I believe that what we see from our windows in the street is what we must have inside our workplaces. In an ideal world we should all have the same opportunities, but unfortunately this is somehow far from the truth. We need to motivate our young Black chemists to aim for a career in science by providing welcoming environments and real opportunities instead of just ticking boxes. We need to showcase our Black chemists to show to the younger generation that they can also be one of us.
What was it that led you to study chemistry and ultimately develop a career in this field? Was this your first choice?
I have always been passionate about research and science. My father had a pharmacy, so I was always close to chemistry and was a very curious child. Yes, it was my first choice but the lack of opportunities and trust from universities and scholarship providers made it a long run. My motivation faded and I nearly gave up.
Was there any one person or group of people who had a specific impact on your decision to pursue your career path?
Yes, but after my degree I nearly gave up. It took me nearly two years and changing cities to find something (a voluntary position). I was always keen on taking up mentors to show me how to progress in my career. There were a few people who helped me by training me and teaching me how to navigate the scientific world and pursue a career in science.
I only got my first job (which I worked for free) because of Peter Stambrook, an American scholar from the University of Cincinnati, who I met through a friend while polishing glasses in a restaurant. This man was open and keen to put a word in for me at a leading university in the UK. He taught me so much on how to be a scientist and humbly grow up and make a career in science. Eventually, all his advice kept me on the right path.
What impact would you like to see #BlackInChem have over the coming year?
More Black students in postgraduate courses and an increase in role models to motivate the younger generations to pursue careers in chemistry.
Could you outline the route that you took to get to where you are now, and how you were supported?
Personally, my career path was far from easy. I only managed to get my PhD at 38 years of age. I needed to first prove myself. Despite all my efforts and dozens of applications, I was never considered a good candidate. I needed to work for free for two years to land a proper job in my field of choice. During that time I took on many odd jobs to support myself. I worked for a top 10 university for free and they never saw my worth or gave me an opportunity. With that experience I landed a proper job at a leading pharmaceutical company. After one year with them, they funded my PhD studies and now here I am with a career in science.
Considering your own career route, what message do you have for people who would like to follow in your footsteps?
Never ever give up - it is possible. Look for the right mentors and be humble. You do not need to reinvent the wheel, but only to find someone who can lend you theirs. Learn to grow from the experiences of others and be ready to fail a couple of times - we all do. Be open to learn and never be afraid of following your dreams.
>> At SCI, we’re proud to support #BlackinChem. Reach out to us with your stories.
What do you think are the specific barriers that might be preventing young black people from pursuing chemistry/science?
I think one of the biggest barriers that prevent people from pursuing careers in science is the lack of role models. If we only show advertisements for chemistry degrees with White people, it’s not encouraging for Black students to pursue a career there. The same goes for when we visit universities; role models are needed. No one wants to be the only Black person in the department. Universities need to embrace diversity at all levels. I understand that tradition sometimes prevents this, but we need to change and ignore tradition for a bit.
What steps do you think can be taken by academia and businesses to increase the number of Black people studying and pursuing chemistry/science as a career?
Showcase Black chemists and inventors to motivate the younger generations and show society that Black people are not only artists and musicians. Target extracurricular activities in schools where children are from disadvantaged backgrounds. Train your staff to be open. Create cultural events that not only target Black people but also for other people to learn and see that in the end we are all equal. We all need to learn to embrace our differences and grow together.
>> As we celebrate #BlackinChem, we mark the achievements of some inspirational chemists. Read more about the amazing career of Percy Lavon Julian.
This week SCI is joining with business and academia to mark #BlackInChem, an initiative to advance and promote a new generation of Black chemists.
Over the coming weeks, we shall be profiling past and present Black chemists, many of whom are unsung heroes, and whose work established the foundations on which some of our modern science is built. We start with the outstanding contribution made by Percy Lavon Julian (1899-1975).
Born on 11 April 1899 in Montgomery, Alabama, US, Percy L Julian was the son of a clerk at the United State Post Office and a teacher. He did well at school, and even though there were no public high schools for African Americans in Montgomery, he was accepted at DePauw University, Indiana, in 1916.
Due to segregation Julian had to live off campus, even struggling initially to find somewhere that would serve him food. As well as completing his studies, he worked to pay his college expenses. Excelling in his studies, he graduated with a BA in 1920.
Julian wanted to study chemistry, but with little encouragement to continue his education, based on the fact there were few job opportunities, he found a position as a chemistry instructor at Fisk University, Nashville, Tennessee.
In 1922 Julian won an Austin Fellowship to Harvard University and received his MA in 1923. With no job offers forthcoming, he served on the staff of predominantly Black colleges, first at West Virginia State College and in 1928 as head of the department of chemistry at Howard University.
In 1929 Julian received a Rockefeller Foundation grant and the chance to earn his doctorate in chemistry. He studied natural products chemistry with Ernst Späth, an Austrian chemist, at the University of Vienna and received his PhD in 1931. He returned to Howard University, but it is said that internal politics forced him to leave.
Physostigmine was synthesised by Julian
Julian returned to DePauw University as a research fellow during 1933. Collaborating with fellow chemist and friend Josef Pikl, he completed research, in 1935, that resulted in the synthesis of physostigmine. His work was published in the Journal of the American Chemical Society.
Physostigmine, an alkaloid, was only available from its natural source, the Calabar bean, the seed of a leguminous plant native to tropical Africa. Julian’s research and synthesis process made the chemical readily available for the treatment of glaucoma. It is said that this development was the most significant chemical research publication to come from DePauw.
Once the grant funding had expired, and despite efforts of those who championed his work, the Board of Trustees at DePauw would not allow Julian to be promoted to teaching staff. He left to pursue a distinguished career in industry. It is said that he was denied one particular position as a town law forbid ‘housing of a Negro overnight.’ Other companies are also said to have rejected him because of his race.
However, in 1936 he was offered a position as director of research for soya products at Glidden in Chicago. Over the next 18 years, the results of his soybean protein research produced numerous patents and successful products for Glidden. These included a paper coating and a fire-retardant foam used widely in World War II to extinguish gasoline fires. Julian’s biomedical research made it possible to produce large quantities of synthetic progesterone and hydrocortisone at low cost.
Percy Lavon Julian | Editorial credit: spatuletail / Shutterstock.com
By 1953 Julian Laboratories had been established, an enterprise that he went on to sell for more than $2 million in 1961. He then established the Julian Research Institute, a non-profit research organisation. In 1967 he was appointed to the DePauw University Board of Trustees, and in 1973 he was elected to the National Academy of Sciences, the second African American to receive the honour.
He was also widely recognised as a steadfast advocate of human rights. Julian continued his private research studies and served as a consultant to major pharmaceutical companies until his death on 19 April 1975. Percy Lavon Julian is commemorated at DePauw University with the Percy L Julian Science and Mathematics Center named in his honour. During 1993 the United States Postal Service commemorated Julian on a stamp in recognition of his extraordinary contribution to science and society.
Every day, there are subtle signs that machine learning is making our lives easier. It could be as simple as a Netflix series recommendation or your phone camera automatically adjusting to the light – or it could be something even more profound. In the case of two recent machine-learning developments, these advances could make a tangible difference to both microscopy, cancer treatment, and our health.
The first is an artificial intelligence (AI) tool that improves the information gleaned from microscopic images. Researchers at the University of Gothenburg have used this deep machine learning to enhance the accuracy and speed of analysis.
The tool uses deep learning to extract as much information as possible from data-packed images. The neural networks retrieve exactly what a scientist wants by looking through a huge trove of images (known as training data). These networks can process tens of thousands of images an hour whereas some manual methods deliver about a hundred a month.
Machine learning can be used to follow infections in a cell.
In practice, this algorithm makes it easier for researchers to count and classify cells and focus on specific material characteristics. For example, it can be used by companies to reduce emissions by showing workers in real time whether unwanted particles have been filtered out.
“This makes it possible to quickly extract more details from microscope images without needing to create a complicated analysis with traditional methods,” says Benjamin Midtvedt, a doctoral student in physics and the main author of the study. “In addition, the results are reproducible, and customised. Specific information can be retrieved for a specific purpose."
The University of Gothenburg tool could also be used in health care applications. The researchers believe it could be used to follow infections in a cell and map cellular defense mechanisms to aid the development of new medicines and treatments.
Machine learning by colour
On a similar thread, machine learning has been used to detect cancer by researchers from the National University of Singapore. The researchers have used a special dye to colour cells by pH and a machine learning algorithm to detect the changes in colour caused by cancer.
The researchers explain in their APL Bioengineering study that the pH (acidity level) of a cancerous cell is not the same as that of a healthy cell. So, you can tell if a cell is cancerous if you know its pH.
With this in mind, the researchers have treated cells with a pH-sensitive dye called bromothymol blue that changes colour depending on how acidic the solution is. Once dyed, each cell exudes its unique red, green, and blue fingerprint.
By isolating a cell’s pH, researchers can detect the presence of cancer.
The authors have also trained a machine learning algorithm to map combinations of colours to assess the state of cells and detect any worrying shifts. Once a sample of the cells is taken, medical professionals can use this non-invasive method to get a clearer picture of what is going on inside the body. And all they need to do all of this is an inverted microscope and a colour camera.
“Our method allowed us to classify single cells of various human tissues, both normal and cancerous, by focusing solely on the inherent acidity levels that each cell type tends to exhibit, and using simple and inexpensive equipment,” said Chwee Teck Lim, one of the study’s authors.
“One potential application of this technique would be in liquid biopsy, where tumour cells that escaped from the primary tumour can be isolated in a minimally invasive fashion from bodily fluids.”
The encouraging sign for all of us is that these two technologies are but two dots on a broad canvas, and machine learning will enhance analysis. There are certainly troubling elements to machine learning but anything that helps hinder disease is to be welcomed.
Machine Learning-Based Approach to pH Imaging and Classification of Single Cancer Cells:
Quantitative Digital Microscopy with Deep Learning: